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Performance of commercially available component
resolved microarray has not been widely evaluated in
food allergy. Fruit allergy is a prevalent food allergy in
which component resolved diagnosis is crucial.
In the context of a multicentric study on pollen and
vegetable food allergy in Spain, we enrolled patients
(n=137) who had suffered at least two episodes of
immediate symptoms after ingestion of fruits (peach,
apple or kiwi). Skin prick test was positive for the corre-
sponding nut. ImmunoCAP ISAC 112 was analyzed in
all patients and ImmunoCAP to the available compo-
nents from the studied sources were analyzed (Pru p 1,
Pru p 3, Mal d 1, Act d 1, Act d 2, Act d 5, Act d 8) in
those patients showing negative result to ISAC.
Among the 107 patients allergic to peach, 7 were sen-
sitized to Pru p 1 and 90 to Pru p 3. Fifteen peach-aller-
gic patients showed no sensitization to any of these
components in the microarray. Among these 15 ISAC
negative peach allergic patients, 2 were sensitized to Pru
p 1 and 9 to Pru p 3 by CAP.
Among the 25 patients allergic to kiwi, 6 were sensi-
tized to Act d 1, 3 to Act d 2, 1 to Act d 5 and none to
Act d 8. Sixteen patients allergic to kiw showed no sen-
sitization to any components in the microarray. Among
these 16 ISAC negative kiwi allergic patients, no patients
were sensitized to the only available kiwi component by
CAP Act d 8.
Among the 52 patients allergic to apple, 6 were sensi-
tized to Mal d 1. Forty-six apple allergic patients showed
no sensitization to any components by the microarray
technique. Forty-two were sensitized to Pru p 3 by
ISAC. Among the 46 ISAC negative apple allergic
patients, none were sensitized to Mal d 1 by CAP.
Among the 137 patients allergic to peach, apple or
kiwi, 67 patients (49%) did not show specific IgE against
the studied nuts/ components in ISAC.
Sensitization to the lipid transfer protein Pru p 3 not
detected by ISAC was recovered by CAP analysis in 60%
of the cases. In apple allergic patients LTP sensitization
is very prevalent in our area. Therefore, Mal d 3 should
be included in a new version of ISAC.
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